Literature DB >> 23920268

Successful treatment of refractory anti-signal recognition particle myopathy using abatacept.

Keisuke Maeshima1, Yasuhiro Kiyonaga, Chiharu Imada, Mikako Iwakura, Hajime Hamasaki, Miwa Haranaka, Koji Ishii.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23920268     DOI： 10.1093/rheumatology/ket251

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

Review 1.  Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.

Authors:  Siamak Moghadam-Kia; Rohit Aggarwal; Chester V Oddis
Journal:  Expert Rev Clin Immunol       Date:  2015-08-27       Impact factor: 4.473

Review 2.  Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors:  Pari Basharat; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

Review 3.  Treatment in myositis.

Authors:  Chester V Oddis; Rohit Aggarwal
Journal:  Nat Rev Rheumatol       Date:  2018-03-29       Impact factor: 20.543

4.  Therapeutic management of immune-mediated necrotizing myositis.

Authors:  Emma Weeding; Eleni Tiniakou
Journal:  Curr Treatm Opt Rheumatol       Date:  2021-03-29

Review 5.  Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

Authors:  Siamak Moghadam-Kia; Chester V Oddis; Rohit Aggarwal
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.